SCHEMBL216077

SCHEMBL216077

C1CCC2OCCC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16878743 0.97 ALDH1A1 (0.37)
SCHEMBL873330 0.97 ALDH1A1 (0.37)
SCHEMBL19550911 0.94
SCHEMBL124218 0.94
SCHEMBL11377504 0.94
SCHEMBL19551074 0.94
SCHEMBL122714 0.94
SCHEMBL12906709 0.94
SCHEMBL8173625 0.94
SCHEMBL9987268 0.91 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1006 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115058147-A Ultraviolet curing epoxy packaging ink based on cycloalkane, and preparation method and application thereof 西安思摩威新材料有限公司 2022-09-16 CN claimed
EP-3109309-B1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2022-06-08 EP claimed
EP-3109308-B1 PERFUME SYSTEMS PROCTER & GAMBLE (US) 2022-06-01 EP claimed
WO-2022105660-A1 CYCLOALKANE-BASED ULTRAVIOLET CURING PACKAGING INK, USE METHOD THEREFOR AND USE THEREOF 西安思摩威新材料有限公司 2022-05-27 WO claimed
CN-113861128-A Polymerizable compound and optically anisotropic body 江苏创拓新材料有限公司 2021-12-31 CN claimed
CN-111072606-B Octahydrobenzofuran derivative, preparation method and application thereof 北京理工大学 2021-08-06 CN claimed
CN-112457714-A Cycloparaffin-based ultraviolet curing packaging ink and use method and application thereof 西安思摩威新材料有限公司 2021-03-09 CN claimed
CN-111072606-A Octahydrobenzofuran derivative, preparation method and application thereof 北京理工大学 2020-04-28 CN claimed
CN-107484766-A Agricultural chemicals and preparation, application process based on natural cumarin essential oil in common fig leaf juice 郑州市汇川农业科技有限公司 2017-12-19 CN claimed
CN-107050030-A Selective histamine H 4 receptor antagonist for treating vestibular disorder 国立健康与医学研究所 2017-08-18 CN claimed
CN-104582703-A H4 receptor inhibitors for treating tinnitus SENSORION 2015-04-29 CN claimed
EP-1852420-B1 Indole compounds for treating respiratory disorders ONO PHARMACEUTICAL CO (JP) 2012-10-17 EP claimed
CN-102325566-A Selective histamine h4 receptor antagonists for the treatment of vestibular disorders INST NAT SANTE RECH MED 2012-01-18 CN claimed
EP-2121701-A1 METHOD FOR THE PRODUCTION OF HIGH-PURITY 4A, 5, 9, 10, 11, 12,-HEXAHYDRO-6H-BENZOFURO [3A, 3, 2-EF] (2) BENZAZEPINE, AND THE DERIVATIVES THEREOF Sanochemia Pharmazeutika AG (AT) 2009-11-25 EP claimed
WO-2008101266-A1 METHOD FOR THE PRODUCTION OF HIGH-PURITY 4A, 5, 9, 10, 11, 12,-HEXAHYDRO-6H-BENZOFURO [3A, 3, 2-EF] [2] BENZAZEPINE, AND THE DERIVATIVES THEREOF SANOCHEMIA PHARMAZEUTIKA AG (AT) 2008-08-28 WO claimed
US-7402580-B2 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-07-22 US claimed
US-12630510-B2 EP2 antagonist ONO PHARMACEUTICAL CO., LTD. (JP) 2026-05-19 US disclosed
EP-4727924-A1 INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION ONO Pharmaceutical Co., Ltd. (JP) 2026-04-22 EP disclosed
EP-0083093-A3 PROCESS AND INTERMEDIATES OF OCTAHYDROBENZOFURO(3,2-E)ISOQUINOLINES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-05-23 EP disclosed
EP-0083093-A2 Process and intermediates of octahydrobenzofuro(3,2-e)isoquinolines E.I. DU PONT DE NEMOURS AND COMPANY (US) 1983-07-06 EP disclosed